Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.1756
+0.0029 (1.68%)
At close: Sep 3, 2026, 4:00 PM EDT
0.1769
+0.0013 (0.74%)
Pre-market: Sep 4, 2026, 7:34 AM EDT
Gossamer Bio Revenue
Gossamer Bio had revenue of $9.24M in the quarter ending June 30, 2026, a decrease of -19.59%. This brings the company's revenue in the last twelve months to $53.29M, up 32.43% year-over-year. In the year 2025, Gossamer Bio had annual revenue of $48.47M, down -57.74%.
Revenue (ttm)
$53.29M
Revenue Growth
+32.43%
P/S Ratio
1.61
Revenue / Employee
$328,926
Employees
162
Market Cap
85.84M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 48.47M | -66.23M | -57.74% |
| Dec 31, 2024 | 114.70M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Fortress Biotech | 68.47M |
| ImmuCell | 30.68M |
| Rallybio | 646.00K |
| Cardiff Oncology | 508.00K |
| iBio, Inc. | 100.00K |
GOSS News
- 23 hours ago - Gossamer Bio Proxy statement: Proxy filing - Filings
- 13 days ago - Gossamer Bio announces upt to $250M structured private placement - TheFly
- 13 days ago - Gossamer Bio Announces Up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval - Business Wire
- 18 days ago - Gossamer Bio reports Q2 EPS (8c), consensus (12c) - TheFly
- 18 days ago - Gossamer Bio price target lowered to $4 from $15 at Piper Sandler - TheFly
- 21 days ago - Gossamer Bio Announces Second Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 22 days ago - Gossamer Bio Quarterly report: Q2 2026 - Filings
- 22 days ago - Gossamer Bio Earnings release: Q2 2026 - Filings